The combined maternal administration of magnesium sulfate and aminophylline reduces intraventricular hemorrhage in very preterm neonates.
暂无分享,去创建一个
G. Luzi | G. D. Di Renzo | S. Gerli | G. Clerici | M. Mignosa | L. Burnelli | F. Taddei | D. Marinelli | P. Bragetti | D. Mezzetti | B. Della Torre | A. Fantauzzi | M. Lungarotti | M. S. Lungarotti
[1] R. Romero,et al. Pharmacokinetics of intravenous theophylline in pregnant patients at term. , 2008, American journal of perinatology.
[2] P. Crowley,et al. Prophylactic corticosteroids for preterm birth. , 2006, The Cochrane database of systematic reviews.
[3] B. Schmidt,et al. Controversies surrounding xanthine therapy. , 2004, Seminars in neonatology : SN.
[4] L. Doyle,et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. , 2003, JAMA.
[5] G. Hankins,et al. Temporal and demographic trends in cerebral palsy--fact and fiction. , 2003, American journal of obstetrics and gynecology.
[6] M. Yeargin-Allsopp,et al. Trends in the prevalence of cerebral palsy in a population-based study. , 2002, Pediatrics.
[7] R. Berger,et al. Perinatal Brain Damage: Underlying Mechanisms and Neuroprotective Strategies , 2002, The Journal of the Society for Gynecologic Investigation: JSGI.
[8] D. Altman,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[9] J. Dambrosia,et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. , 2002, The Journal of pediatrics.
[10] R. Berger,et al. Neuroprotective effects of magnesium on Metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation: Mediation by nitric oxide system , 2002 .
[11] A. Spitzer,et al. Magnesium sulfate and neonatal outcomes of preterm neonates , 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[12] A Whitelaw,et al. Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions. , 2001, Seminars in neonatology : SN.
[13] K. Nelson,et al. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. , 2000, American journal of obstetrics and gynecology.
[14] R. Mittendorf,et al. An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy , 2000, Journal of perinatal medicine.
[15] Yves Garnier,et al. Pathophysiology of perinatal brain damage , 1999, Brain Research Reviews.
[16] J. Canterino,et al. Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. , 1999, Obstetrics and gynecology.
[17] B. Khoshnood,et al. If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact? , 1998, Obstetrics and gynecology.
[18] B. Khoshnood,et al. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? , 1997, The Lancet.
[19] N. Paneth,et al. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. , 1997, Pediatrics.
[20] C. Berg,et al. Prenatal Magnesium Sulfate Exposure and the Risk for Cerebral Palsy or Mental Retardation Among Very Low-Birth-Weight Children Aged 3 to 5 Years , 1996 .
[21] W. H. Hall,et al. Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes , 1995 .
[22] K. Nelson,et al. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? , 1995, Pediatrics.
[23] R H Petrie,et al. Pharmacologic effects on labor: effects of drugs on dystocia, labor, and uterine activity. , 1987, Clinical obstetrics and gynecology.
[24] A. Stark,et al. Respiratory distress syndrome. , 1986, Pediatric clinics of North America.
[25] E. Cosmi,et al. Effect of aminophylline on lung maturation in preterm rabbit fetuses. , 1986, American journal of obstetrics and gynecology.
[26] E. Bancalari,et al. Effects of Aminophylline on Respiratory Center and Reflex Activity in Premature Infants with Apnea , 1983, Pediatric Research.
[27] J. Lipshitz. Uterine and cardiovascular effects of aminophylline. , 1978, American journal of obstetrics and gynecology.
[28] R. Blackwell,et al. THE VALUE OF A SCORING SYSTEM IN PREDICTING OUTCOME OF PRE‐TERM LABOUR AND COMPARING THE EFFICACY OF TREATMENT WITH AMINOPHYLLINE AND SALBUTAMOL , 1978, British journal of obstetrics and gynaecology.
[29] W. Oh,et al. Acceleration of Fetal Lung Maturation by Aminophyllin in Pregnant Rabbits , 1976, Pediatric Research.
[30] L. Beerman,et al. Are chest radiographs and electrocardiograms still valuable in evaluating new pediatric patients with heart murmurs or chest pain? , 1997, Pediatrics.
[31] I. Ramzan,et al. Theophylline neurotoxicity in pregnant rats. , 1988, Life sciences.
[32] D. Phelps,et al. Effects of Cortisol and Aminophylline upon Survival, Pulmonary Mechanics, and Secreted Phosphatidyl Choline of Prematurely Delivered Rabbits , 1978, Pediatric Research.